Brief: Consun Pharmaceutical considering spin-off and listing of Guangxi Yulin Pharmaceutical Group
Oct 19 (Reuters) - Consun Pharmaceutical Group Ltd 1681.HK
* Board considering spin-off and listing of Guangxi Yulin
Pharmaceutical Group and its subsidiaries
Source text for Eikon: urn:newsml:reuters.com:*:nHKS96C5bC
Further company coverage: 1681.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Consun Pharmaceutical
See all newsChina's Consun Pharmaceutical H1 revenue rises on sales network expansion
Brief: Consun Pharmaceutical Says Unit To Invest RMB191.4 Mln In Shanghai Huamao Pharmaceutical
Brief: Consun Pharmaceutical Group Announces Share Repurchase Program Up To HKD200 Million
Brief: Consun Pharmaceutical Logs FY Revenue RMB 3,420 Mln
Brief: Consun Pharmaceutical Says Executive Director Zhu Quan Redesignated As Non-Executive Director